Pharma/Biotech – USA, Europe, Asia and ROW Regulatory News – Jan 2025
USA
FDA Approves a New Non-Opioid Therapy for Acute Pain
The U.S. Food and Drug Administration has officially approved for Journavx (suzetrigine) 50 mg oral tablets, marking the introduction...
BioPharma, BioTech, Clinical Trials, Drug Approval, EMA, FDA, Healthcare Pharma Regulations, Pharma News, Regulatory Updates
